Search research articles
Contact Us
Filters
Showing results (31-40 of 62) with videos related to
Page
of 7
Sort By:
ACS Medicinal Chemistry Letters
|
January 25, 2021
Discovery of PIPE-359, a Brain-Penetrant, Selective M<sub>1</sub> Receptor Antagonist with Robust Efficacy in Murine MOG-EAE
Thomas O Schrader, Yifeng Xiong, Ariana O Lorenzana, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 19, 2015
Is skin autofluorescence a marker of metabolic memory in pregnant women with diabetes?
E Maury, J Savel, V Grouthier, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
August 31, 2010
Estrogen receptor (ER) subtype agonists alter monoamine levels in the female rat brain
Laura S Lubbers, Peter T Zafian, Claris Gautreaux, et al.
Brain Research
|
February 5, 2008
Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: Implication in emotional responses and central disinhibition
Guibao Gu, Daniel S Lorrain, Hongbing Wei, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 29, 2016
Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination
Feng Mei, Sonia R Mayoral, Hiroko Nobuta, et al.
Neuropharmacology
|
August 24, 2025
Reduced activation of pain-related brain regions with lysophosphatidic acid receptor subtype-1 antagonist PIPE-791 in a nonhuman primate model of chronic peripheral neuropathy
Aldric Hama, Christopher Baccei, Austin Chen, et al.
Arthritis and Rheumatism
|
February 10, 2011
Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma
Flavia V Castelino, Jon Seiders, Gretchen Bain, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 22, 2014
Identification of the first potent, selective and bioavailable PPARα antagonist
Yalda Bravo, Christopher S Baccei, Alex Broadhead, et al.
Journal of Medicinal Chemistry
|
June 29, 2026
Discovery of <b>PIPE-791</b>, A Potent and Brain-Penetrant Lysophosphatidic Acid Receptor 1 Antagonist with Slow Tight Binding Characteristics for the Treatment of Neuroinflammatory Disorders
Austin Chen, Christopher Baccei, Jill Baccei, et al.
Journal of Medicinal Chemistry
|
August 20, 2004
Phenyl-tetrazolyl acetophenones: discovery of positive allosteric potentiatiors for the metabotropic glutamate 2 receptor
Anthony B Pinkerton, Jean-Michel Vernier, Hervé Schaffhauser, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 62) with videos related to
Sort By:
Page
of 7
ACS Medicinal Chemistry Letters
|
January 25, 2021
Discovery of PIPE-359, a Brain-Penetrant, Selective M<sub>1</sub> Receptor Antagonist with Robust Efficacy in Murine MOG-EAE
Thomas O Schrader, Yifeng Xiong, Ariana O Lorenzana, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 19, 2015
Is skin autofluorescence a marker of metabolic memory in pregnant women with diabetes?
E Maury, J Savel, V Grouthier, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
August 31, 2010
Estrogen receptor (ER) subtype agonists alter monoamine levels in the female rat brain
Laura S Lubbers, Peter T Zafian, Claris Gautreaux, et al.
Brain Research
|
February 5, 2008
Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: Implication in emotional responses and central disinhibition
Guibao Gu, Daniel S Lorrain, Hongbing Wei, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 29, 2016
Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination
Feng Mei, Sonia R Mayoral, Hiroko Nobuta, et al.
Neuropharmacology
|
August 24, 2025
Reduced activation of pain-related brain regions with lysophosphatidic acid receptor subtype-1 antagonist PIPE-791 in a nonhuman primate model of chronic peripheral neuropathy
Aldric Hama, Christopher Baccei, Austin Chen, et al.
Arthritis and Rheumatism
|
February 10, 2011
Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma
Flavia V Castelino, Jon Seiders, Gretchen Bain, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 22, 2014
Identification of the first potent, selective and bioavailable PPARα antagonist
Yalda Bravo, Christopher S Baccei, Alex Broadhead, et al.
Journal of Medicinal Chemistry
|
June 29, 2026
Discovery of <b>PIPE-791</b>, A Potent and Brain-Penetrant Lysophosphatidic Acid Receptor 1 Antagonist with Slow Tight Binding Characteristics for the Treatment of Neuroinflammatory Disorders
Austin Chen, Christopher Baccei, Jill Baccei, et al.
Journal of Medicinal Chemistry
|
August 20, 2004
Phenyl-tetrazolyl acetophenones: discovery of positive allosteric potentiatiors for the metabotropic glutamate 2 receptor
Anthony B Pinkerton, Jean-Michel Vernier, Hervé Schaffhauser, et al.
Page
of 7